Parkinson's Disease

2003/09/01 by William Dauer, William T. Dauer, Serge Przedborski · 29 citations
Medicine · Neuroscience · #Genetic Neurodegenerative Diseases #Neurological disorders and treatments #Parkinson's Disease Mechanisms and Treatments

paper · pdf · doi:10.1016/s0896-6273(03)00568-3

openalex publication_date 2003/09/01 · openalex created_date 2016/06/24 · openalex updated_date 2026/07/30

Citations

• PHASE AND ELECTRON MICROSCOPIC OBSERVATIONS OF LEWY BODIES AND MELANIN GRANULES IN THE SUBSTANTIA NIGRA AND LOCUS CAERULEUS IN PARKINSONʼS DISEASE
• Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic Membranes

Cited by

• Weakly Supervised Segmentation and Classification of Alpha-Synuclein Aggregates in Brightfield Midbrain Images
• Multimodal characterization of cortical amplitude of low-frequency fluctuation alterations in chronic low back pain: integrating functional MRI, transcriptomics, and neurochemical mapping
• Multi-View Graph Convolutional Network and Its Applications on Neuroimage Analysis for Parkinson's Disease
• Levodopa treatment: impacts and mechanisms throughout Parkinson’s disease progression
• A somato-cognitive action network alternates with effector regions in motor cortex
• Meaningful Associations Redux: Quantifying and interpreting effect size in the context of the Adolescent Brain and Cognitive Development study
• Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
• Alternative pre-mRNA Splicing and Gene Expression Patterns in Midbrain Lineage Cells Carrying Familial Parkinson’s Disease Mutations
• L347P PINK1 mutant that fails to bind to Hsp90/Cdc37 chaperones is rapidly degraded in a proteasome-dependent manner
• Challenges of Organoid Research
• Investigation of the pharmacological, behavioral and biochemical effects of boron on rats with rotenone-induced Parkinson's Disease
• TransformEEG: Towards Improving Model Generalizability in Deep Learning-based EEG Parkinson's Disease Detection
• Methyl-4-phenylpyridinium (MPP +) differentially affects monoamine release and re-uptake in murine embryonic stem cell-derived dopaminergic and serotonergic neurons
• Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
• The Effect of Microwaves on Protein Structure: Molecular Dynamics Approach
• Awareness and current knowledge of Parkinson’s disease: a neurodegenerative disorder
• Induction of KLF4 Contributes to the Neurotoxicity of MPP + in M17 Cells: A New Implication in Parkinson’s Disease
• Determinants of dopaminergic neuron loss in Parkinson's disease
• Atypical Parkinsonism in the French West Indies: The Plant Toxin Annonacin as a Potential Etiological Factor
• A Methodological and Structural Review of Parkinsons Disease Detection Across Diverse Data Modalities
• Transgenic rodent models of Parkinson’s disease
• Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models?
• Biomedical and Clinical Promises of Human Pluripotent Stem Cells for Neurological Disorders
• Mitochondrial dysfunction and molecular pathways of disease
• α-Synuclein Budding Yeast Model: Toxicity Enhanced by Impaired Proteasome and Oxidative Stress
• Parkinson's Disease: Genetics and Pathogenesis
• Protein Aggregation in the Brain: The Molecular Basis for Alzheimer’s and Parkinson’s Diseases
• Naringenin as a multi-target neuroprotective agent in neurodegenerative diseases
• Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice